Press Release
May 9, 2023
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2023
More
May 3, 2023
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023
More
April 24, 2023
Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023
More
April 12, 2023
Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
More
March 8, 2023
Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg
More
February 28, 2023
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2022
More
February 22, 2023